Found 288 matching trials
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma PHASE2 The investigators conducted a phase II, prospective, two-arm clinical study...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma PHASE2 The study is being conducted to evaluate the efficacy and safety of convers...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer PHASE2 To evaluate the efficacy and safety of short-course radiotherapy followed b...
Show More Location
Multiple Locations
Learn More & Join Trial
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma N/A Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial
Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION) PHASE3 The study is a multicenter, open-label, randomized controlled clinical stud...
Show More Status
Active Not Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
A Multicenter Phase II Clinical Study of Neoadjuvant Use of Camrelizumab in Combination With Chemotherapy for Organ Preservation in Esophageal Cancer PHASE2 This is a multicenter phase II clinical study to explore the efficacy, safe...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC PHASE1 Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Show More Location
the First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. PHASE2 This is a prospective single-arm exploratory clinical study. The efficacy a...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer PHASE2 According to the investigator's judgment, there are concomitant diseases th...
Show More Location
Shengjing Hospital of China Medical University
Learn More & Join Trial